(Q44254692)

English

A phase 3, randomized, double-blind trial comparing the safety and immunogenicity of the 7-valent and 13-valent pneumococcal conjugate vaccines, given with routine pediatric vaccinations, in healthy infants in Brazil

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

A phase 3, randomized, double-blind trial comparing the safety and immunogenicity of the 7-valent and 13-valent pneumococcal conjugate vaccines, given with routine pediatric vaccinations, in healthy infants in Brazil (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

phase III clinical trial

0 references

William C. Gruber

8

object named as

William C Gruber

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1

object named as

Lily Yin Weckx

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

author name string

Allison Thompson

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Eitan Naaman Berezin

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sonia Maria de Faria

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Clovis Arns da Cunha

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Michael Pride

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Scott Patterson

7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Emilio A Emini

9

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Daniel A Scott

10

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

012 Study Group

11

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

language of work or name

0 references

publication date

22 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

7566-7572

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Impact of pneumococcal conjugate vaccine on the prevention of invasive pneumococcal diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.040

7 January 2021

Distribution of Streptococcus pneumoniae serotypes in nasopharyngeal carriage and in invasive pneumococcal disease in Sao Paulo, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.040

7 January 2021

Serotypes of carriage and invasive isolates of Streptococcus pneumoniae in Brazilian children in the era of pneumococcal vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.040

7 January 2021

Increase in numbers of beta-lactam-resistant invasive Streptococcus pneumoniae in Brazil and the impact of conjugate vaccine coverage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.040

7 January 2021

Estimating the cost-effectiveness of pneumococcal conjugate vaccination in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.040

7 January 2021

Safety and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers Given With Routine Pediatric Vaccinations in Canada

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.040

7 January 2021

13-valent pneumococcal conjugate vaccine given with meningococcal C-tetanus toxoid conjugate and other routine pediatric vaccinations: immunogenicity and safety

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.040

7 January 2021

Antibody responses to routine pediatric vaccines administered with 13-valent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.040

7 January 2021

Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.040

7 January 2021

Acellular pertussis vaccines for adolescents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.040

7 January 2021

Test-based exact confidence intervals for the difference of two binomial proportions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.040

7 January 2021

Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.040

7 January 2021

A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.040

7 January 2021

Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.040

7 January 2021

Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.040

7 January 2021

Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.040

7 January 2021

Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.040

7 January 2021

Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.040

7 January 2021

Immunogenicity, reactogenicity and consistency of production of a Brazilian combined vaccine against diphtheria, tetanus, pertussis and Haemophilus influenzae type b

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.040

7 January 2021

Hypotonic-hyporesponsive episode (HHE) as an adverse event following immunization in early childhood: case definition and guidelines for data collection, analysis, and presentation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.040

7 January 2021

Identifiers

10.1016/J.VACCINE.2012.10.040

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44254692&oldid=2108933650"